US Stock MarketDetailed Quotes
SXTP 60 Degrees Pharmaceuticals
- 1.170
- +0.270+30.00%
Close Nov 25 16:00 ET
- 1.170
- 0.0000.00%
Pre 04:17 ET
2.18MMarket Cap-605P/E (TTM)
1.200High0.920Low330.46KVolume0.920Open0.900Pre Close356.65KTurnover20.98%Turnover RatioLossP/E (Static)1.86MShares18.36052wk High-0.32P/B1.84MFloat Cap0.70252wk Low--Dividend TTM1.58MShs Float103.800Historical High--Div YieldTTM31.11%Amplitude0.701Historical Low1.079Avg Price1Lot Size
60 Degrees Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 164.31%135.29K | 109.92%124.97K | 578.21%116.46K | 13.60%253.57K | 438.09%125.68K | -69.56%51.19K | 31.79%59.53K | -63.48%17.17K | -80.76%223.21K | -226.17%-37.17K |
| Operating revenue | 164.31%135.29K | 109.92%124.97K | 578.21%116.46K | 13.60%253.57K | 438.09%125.68K | -69.56%51.19K | 31.79%59.53K | -63.48%17.17K | -80.76%223.21K | -226.17%-37.17K |
| Cost of revenue | 56.87%111.69K | -51.32%89.56K | -10.51%65.44K | 9.76%474.55K | -10.18%146.26K | -22.85%71.2K | 111.18%183.98K | -18.88%73.12K | -49.18%432.37K | 127.36%162.84K |
| Gross profit | 217.98%23.61K | 128.45%35.41K | 191.20%51.03K | -5.65%-220.98K | 89.71%-20.58K | -126.36%-20.01K | -196.67%-124.45K | -29.78%-55.95K | -167.56%-209.16K | -374.46%-200.01K |
| Operating expense | 42.65%2.14M | 536.60%4.22M | 54.54%1.38M | 220.10%4.93M | 286.55%1.87M | 416.03%1.5M | 2.88%663.55K | 641.87%894.72K | 7.50%1.54M | 10.22%484.69K |
| Selling and administrative expenses | -7.50%1.22M | 144.07%1.13M | 38.72%1.08M | 225.36%4.24M | 446.06%1.69M | 217.58%1.31M | 14.03%462.8K | 343.65%775.01K | 16.89%1.3M | 17.63%309.57K |
| -General and administrative expense | -7.50%1.22M | 144.07%1.13M | 38.72%1.08M | 225.36%4.24M | 446.06%1.69M | 217.58%1.31M | 14.03%462.8K | 343.65%775.01K | 16.89%1.3M | 17.63%309.57K |
| Research and development costs | 256.49%940.06K | 1,418.27%3.1M | 171.93%337.18K | 31.62%691.77K | -50.75%100.2K | 853.55%263.7K | -11.89%203.87K | 96.64%123.99K | -90.46%525.56K | -53.09%203.46K |
| Other operating expenses | 83.04%-12.82K | 76.64%-728 | -590.38%-29.63K | ---- | ---- | 49.71%-75.57K | -140.26%-3.12K | 96.34%-4.29K | 94.45%-288K | 88.98%-28.33K |
| Operating profit | -39.23%-2.12M | -431.57%-4.19M | -40.08%-1.33M | -194.47%-5.15M | -176.64%-1.89M | -607.41%-1.52M | -14.71%-788K | -480.69%-950.66K | -55.72%-1.75M | -42.09%-684.7K |
| Net non-operating interest income expense | 96.34%-1.47K | 99.67%-3.62K | 99.88%-1.4K | 42.68%-2.29M | 99.51%-5.45K | 96.70%-40.11K | -21.44%-1.1M | -49.75%-1.14M | -25.74%-3.99M | -20.04%-1.11M |
| Non-operating interest expense | -96.34%1.47K | -99.67%3.62K | -99.88%1.4K | -42.68%2.29M | -99.51%5.45K | -96.70%40.11K | 21.44%1.1M | 49.75%1.14M | 25.74%3.99M | 20.04%1.11M |
| Other net income (expense) | -100.70%-40.09K | 101.28%18.58K | 448.47%1.76M | 929.22%3.63M | -221.68%-146.55K | 29,782.10%5.74M | -161.22%-1.46M | -2,797.94%-505.38K | -1,266.15%-437.48K | 215.48%120.44K |
| Gain on sale of security | -161.32%-56.71K | 99.72%-1.1K | 34,008.20%1.74M | 15.13%-437K | -1,105.78%-132.6K | 511.16%92.49K | 22.52%-391.76K | ---5.13K | ---514.93K | --13.18K |
| Special income (charges) | --0 | --0 | --0 | -1,120.43%-1.23M | --0 | ---391.59K | --0 | ---839.89K | --120.68K | --120.68K |
| -Less:Other special charges | ---- | ---- | ---- | 1,120.43%1.23M | --0 | --391.59K | ---- | --839.89K | ---120.68K | ---- |
| Other non- operating income (expenses) | -99.72%16.62K | 101.85%19.68K | -94.03%20.26K | 12,348.84%5.3M | -3.87%-13.95K | 190,145.15%6.03M | -1,957.70%-1.06M | 1,713.17%339.64K | -215.26%-43.24K | -135.17%-13.43K |
| Income before tax | -151.76%-2.16M | -24.83%-4.17M | 116.48%428.05K | 38.26%-3.81M | -22.53%-2.05M | 387.75%4.17M | -55.53%-3.34M | -186.32%-2.6M | -45.03%-6.18M | -22.36%-1.67M |
| Income tax | 296.83%250 | 595.24%438 | 0.00%63 | -50.00%250 | 124.40%61 | -74.80%63 | -74.80%63 | -74.80%63 | -50.00%500 | -200.00%-250 |
| Net income | -151.77%-2.16M | -24.84%-4.17M | 116.48%427.99K | 38.27%-3.81M | -22.55%-2.05M | 387.70%4.17M | -55.51%-3.34M | -186.25%-2.6M | -45.01%-6.18M | -22.32%-1.67M |
| Net income continuous Operations | -151.77%-2.16M | -24.84%-4.17M | 116.48%427.99K | 38.27%-3.81M | -22.55%-2.05M | 387.70%4.17M | -55.51%-3.34M | -186.25%-2.6M | -45.01%-6.18M | -22.32%-1.67M |
| Minority interest income | 92.62%-713 | 79.09%-1.47K | -198.34%-2.49K | -1,322.00%-48.1K | -729.55%-33.93K | -204.41%-9.66K | -125.73%-7.04K | -47.74%2.53K | 146.01%3.94K | 235.19%5.39K |
| Net income attributable to the parent company | -151.63%-2.16M | -25.06%-4.17M | 116.56%430.47K | 39.08%-3.77M | -20.13%-2.01M | 389.00%4.18M | -55.41%-3.34M | -185.01%-2.6M | -45.39%-6.18M | -23.07%-1.68M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -151.63%-2.16M | -25.06%-4.17M | 116.56%430.47K | 39.08%-3.77M | -20.13%-2.01M | 389.00%4.18M | -55.41%-3.34M | -185.01%-2.6M | -45.39%-6.18M | -23.07%-1.68M |
| Basic earnings per share | -110.19%-0.93 | 42.80%-4.112 | 106.43%0.36 | 10.80%-11.88 | -46.58%-5.29 | 392.75%9.13 | -55.41%-7.1889 | -185.01%-5.602 | -45.39%-13.319 | -23.07%-3.609 |
| Diluted earnings per share | -110.19%-0.93 | 42.80%-4.112 | 106.43%0.36 | 10.80%-11.88 | -46.58%-5.29 | 392.75%9.13 | -55.41%-7.1889 | -185.01%-5.602 | -45.39%-13.319 | -23.07%-3.609 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data